SCHEMBL22420113

SCHEMBL22420113

CCCCCCC(C)(C)CCN(C)C(=O)CCl

nearest known ligand 0.40

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.40
▸ TP53 P04637 2/20 0.40
▸ NPC1 O15118 2/20 0.40
▸ RAB9A P51151 2/20 0.40
▸ PAX8 Q06710 2/20 0.40
▸ JAK2 O60674 1/20 0.40
▸ GPX4 P36969 1/20 0.39
▸ EPHX2 P34913 2/20 0.36
▸ FFAR1 O14842 1/20 0.35
▸ CPT2 P23786 1/20 0.35
▸ TDP1 Q9NUW8 1/20 0.35
▸ SMPD1 P17405 2/20 0.35
▸ CES2 O00748 1/20 0.35
▸ FDPS P14324 1/20 0.35
▸ DNM1 Q05193 2/20 0.35
▸ SIGMAR1 Q99720 1/20 0.34
▸ FAAH O00519 1/20 0.33
▸ CNR1 P21554 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19069153 0.98 ALDH1A1 (0.38) ALDH1A1TP53NPC1RAB9APAX8
SCHEMBL18737307 0.93 ALDH1A1 (0.36) ALDH1A1TP53NPC1RAB9APAX8
SCHEMBL18857525 0.87 ALDH1A1 (0.42) ALDH1A1TP53NPC1RAB9APAX8
SCHEMBL19240716 0.87 ALDH1A1 (0.42) ALDH1A1TP53NPC1RAB9APAX8
SCHEMBL21166472 0.86 ALDH1A1 (0.41) ALDH1A1TP53NPC1RAB9APAX8
SCHEMBL19176543 0.86 ALDH1A1 (0.41) ALDH1A1TP53NPC1RAB9APAX8
SCHEMBL20216159 0.84 ALDH1A1 (0.40) ALDH1A1TP53NPC1RAB9APAX8
SCHEMBL23639761 0.83 EPHX2 (0.48) ALDH1A1EPHX2CES2DNM1CNR1
SCHEMBL13575332 0.81 ALDH1A1 (0.36) ALDH1A1RAB9A
SCHEMBL9422721 0.81 NPC1 (0.51) ALDH1A1TP53NPC1RAB9APAX8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10774052-B2 Heteroaryl compounds and uses thereof CELGENE CAR LLC (BM) 2020-09-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10774052-B2 Heteroaryl compounds and uses thereof ABCG2, CYP3A43, CYP3A5 ALDH1A1 684/4885TP53 1214/4885NPC1 48/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback